Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.64 |
| ▸ | ECE1 | P42892 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | GHSR | Q92847 | 1/20 | 0.38 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.37 |
| ▸ | GNPAT | O15228 | 1/20 | 0.36 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.36 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.36 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.36 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
| ▸ | FPGS | Q05932 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8832939 | 1.00 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL10595108 | 1.00 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL5598418 | 1.00 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL259085 | 1.00 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL2815080 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL29767981 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL4589314 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL29473319 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL4589903 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL2817828 | 0.99 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4725495-A2 | WEARABLE PHOTOTHERAPY APPARATUS WITH ANTI-VIRAL AND OTHER EFFECTS | Soletluna Holdings, Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| WO-2026040002-A1 | COMPOSITION AND METHOD FOR CARING FOR THE SKIN | L'OREAL (FR) | 2026-02-26 | — | — | WO | claimed |
| US-12220599-B2 | Wearable phototherapy apparatus with anti-viral and other effects | SOLETLUNA HOLDINGS, INC. (US) | 2025-02-11 | — | — | US | claimed |
| CN-116919846-A | Stem cell cytokine-containing composition and application thereof | 国源细胞工程有限责任公司 | 2023-10-24 | — | — | CN | claimed |
| EP-4082607-A1 | WEARABLE PHOTOTHERAPY APPARATUS WITH ANTI-VIRAL AND OTHER EFFECTS | Soletluna Holdings, Inc. (US) | 2022-11-02 | — | — | EP | claimed |
| US-20220096861-A1 | WEARABLE PHOTOTHERAPY APPARATUS WITH ANTI-VIRAL AND OTHER EFFECTS | SOLETLUNA HOLDINGS, INC. (US) | 2022-03-31 | — | — | US | claimed |
| CN-109988304-B | Synthesis method of glycyl histidyl lysine grafted polyaspartic acid derivative | 苏州美瑞姿生物科技有限公司 | 2021-06-08 | — | — | CN | claimed |
| US-10905744-B2 | Pharmaceutical formulations for the oral delivery of peptide drugs | CYPRUMED GMBH (AT) | 2021-02-02 | — | — | US | claimed |
| US-10898724-B2 | Wearable phototherapy apparatus with anti-viral and other effects | SOLETLUNA HOLDINGS, INC. (US) | 2021-01-26 | — | — | US | claimed |
| US-20200391045-A1 | WEARABLE PHOTOTHERAPY APPARATUS WITH ANTI-VIRAL AND OTHER EFFECTS | SOLETLUNA HOLDINGS, INC., (US) | 2020-12-17 | — | — | US | claimed |
| EP-1618125-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | Petron Co., Ltd. (KR) | 2006-01-25 | — | — | EP | claimed |
| EP-1611898-A1 | COMPOSITION FOR THE PREVENTION AND TREATMENT OF CELLULITIS | LIPOTEC, S.A. (ES) | 2006-01-04 | — | — | EP | claimed |
| EP-1534215-A1 | COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND SOFT TISSUE FILLERS | PROCYTE CORPORATION (US) | 2005-06-01 | — | — | EP | claimed |
| WO-2004096837-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO., LTD (KR) | 2004-11-11 | — | — | WO | claimed |
| US-20040106763-A1 | Linear block polymer | ARTIMPLANT AB (SE) | 2004-06-03 | — | — | US | claimed |
| WO-2004004671-A1 | COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND SOFT TISSUE FILLERS | PROCYTE CORPORATION (US) | 2004-01-15 | — | — | WO | claimed |
| EP-1353968-A1 | LINEAR BLOCK POLYMER | Artimplant AB (SE) | 2003-10-22 | — | — | EP | claimed |
| WO-2002053617-A1 | LINEAR BLOCK POLYMER | ARTIMPLANT AB (SE) | 2002-07-11 | — | — | WO | claimed |
| WO-1994018230-A1 | INHIBITION OF HIV REPLICATION BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1994-08-18 | — | — | WO | claimed |
| US-4732155-A | Implantable chemoattractant system | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1988-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10905744-B2 | Pharmaceutical formulations for the oral delivery of peptide drugs | SLC30A5, SLC39A11, SLC30A6 | SLC15A2 94/4885ECE1 1458/4885FOLH1 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.